New QP Declaration for managing Expiry Dates of IMPs
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In the recently published EMA Reflection paper on IVR/IWR systems, an additional QP Declaration is introduced for managing expiry dates. Overall the "Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials" seeks to provide guidance to Member States on what the expectations are on IVR/IWR systems and in particular on their use in expiry updating. In the case such a system is used to control expiry dates, a declaration by the Qualified Person (QP) is needed. This declaration should be part of both the Product Specification File (PSF) and Trial Master File. Annex 1 of the draft document shows what this declaration should look like.
In addition, the sponsor will need to notify the QP of the validation status of the IVR/IWR system (and any audit the sponsor has undertaken).
The end of consultation (deadline for comments) is 15 February 2012. Comments should be provided using this template. The completed comments form should be sent to gcp@ema.europa.eu.
Wolfgang Schmitt
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
11.12.2025Insurance Review in Phase 1 Clinical Trials
11.12.2025EMA Publishes Comments on ICH E21
27.11.2025Final ICH M14 Guideline on the Use of RWD for Safety Assessment
25.11.2025Clinical Trials: BMG publishes Standard Contractual Clauses Ordinance
04.11.2025UK Clinical Trials Regulations: Six-Month Countdown
04.11.2025Clinical Trials - Update on the CTIS